Trial Profile
Pentostatin and Donor Lymphocyte Infusion for Low Donor T-cell Chimerism After Hematopoietic Cell Transplantation - A Multi-center Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Apr 2022
Price :
$35
*
At a glance
- Drugs Pentostatin (Primary) ; Ciclosporin; Mycophenolate mofetil
- Indications Graft-versus-host disease; Haematological malignancies
- Focus Adverse reactions; Therapeutic Use
- 15 Jan 2020 Status changed from active, no longer recruiting to completed.
- 11 Feb 2016 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov record.
- 05 Apr 2013 Planned End Date changed from 1 May 2013 to 1 May 2015 as reported by ClinicalTrials.gov.